Tenax Therapeutics (TENX) Gross Margin (2010 - 2013)

Tenax Therapeutics has disclosed Gross Margin across 4 years of filings, most recently posting 20.52% for Q2 2013.

• In Q2 2013, Gross Margin rose 1495.0% year-over-year to 20.52%; the TTM figure through Dec 2015 stood at 19.07% (changed N/A YoY), while the FY2014 annual figure was 39.57%, down 4373.0% from the prior year.
• Gross Margin came in at 20.52% for Q2 2013 at Tenax Therapeutics, up from 0.6% in the prior quarter.
• In the past five years, Gross Margin ranged from a high of 100.0% in Q4 2010 to a low of 0.6% in Q1 2013.
• Average Gross Margin over 4 years is 40.82%, with a median of 17.78% recorded in 2011.
• Year-over-year, Gross Margin sank 9854 bps in 2012 and surged 1495 bps in 2013.
• Over 4 years, Gross Margin stood at 100.0% in 2010, then tumbled by 82 bps to 17.78% in 2011, then plunged by 94 bps to 1.06% in 2012, then soared by 1843 bps to 20.52% in 2013.
• Per Business Quant data, the three most recent Gross Margin figures were 20.52% in Q2 2013, 0.6% in Q1 2013, and 1.06% in Q4 2012.